What happens when NSAIDs injure the small bowel and cause hidden bleeding, ulcers, protein loss, or diaphragm-like strictures beyond the reach of routine EGD?
Michael’s path through medication review, small-bowel diagnosis, treatment, safer pain planning, and follow-up
Your guardians. GastroDoxs GutGuardians™ is our team of board-certified gastroenterologists - a physician-led defense force of specialists, systems, and solution pathways working together to protect, detect, solve, and defend your digestive health through expert GI evaluation, advanced diagnostic screening, and endoscopic evaluation - commanded from your first concern to your last follow-up, and every critical stage in between.
A 56-year-old regional operations director navigating NSAID enteritis
Michael developed progressive fatigue and iron-deficiency anemia without hematemesis, melena, or obvious rectal bleeding.
He had used ibuprofen and naproxen frequently for chronic back and knee pain, but did not initially consider over-the-counter NSAIDs medically important.
EGD and colonoscopy did not identify a sufficient bleeding source, while capsule endoscopy showed multiple small-bowel erosions and shallow ulcers compatible with NSAID enteropathy after competing causes were reviewed.
His journey focused on withdrawing avoidable NSAIDs, replacing iron, coordinating safer pain control, and reassessing the small bowel only if anemia or symptoms persisted.
The stomach and colon scopes were reassuring, but the bleeding source was in the small bowel. My daily NSAID use finally made sense of the erosions and ulcers on capsule endoscopy.
Michael first noticed reduced stamina rather than abdominal pain.
A falling ferritin and hemoglobin established chronic blood loss or impaired iron balance.
Negative routine upper and lower endoscopy shifted attention toward the small bowel.
The capsule findings became clinically meaningful only after NSAID exposure and alternative causes such as Crohn’s disease were reconciled.
The turning point came when Michael understood that the small-bowel injury needed to be linked to medication exposure, lesion pattern, competing diagnoses, and complication risk.
Michael knew NSAIDs could cause stomach ulcers but did not realize they could also injure jejunal and ileal mucosa.
The GI team explained that NSAID enteropathy can cause erosions, ulcers, occult bleeding, protein loss, strictures, and rarely perforation.
Capsule endoscopy visualized mucosal injury beyond the reach of routine EGD and colonoscopy.
The diagnosis remained one of exclusion because Crohn’s disease, infection, vascular lesions, and other small-bowel disorders can overlap.
The first treatment decision was to stop avoidable NSAID exposure rather than add indefinite acid suppression and assume the small bowel was protected.
The plan had to establish whether NSAIDs truly explained the small-bowel findings, determine whether bleeding or obstruction was present, and create a workable alternative pain or cardiovascular strategy.
The team documented ibuprofen, naproxen, diclofenac, aspirin, prescription NSAIDs, dose, duration, combination use, and the reason each drug was needed.
Hemoglobin, ferritin, iron studies, stool color, anticoagulants, and bleeding symptoms were assessed.
Capsule endoscopy and, when needed, enterography or device-assisted enteroscopy were used according to lesion pattern and stricture risk.
A safer long-term analgesic plan was coordinated so stopping NSAIDs did not leave the underlying pain untreated.
GastroDoxs can review NSAID exposure, iron-deficiency anemia, occult bleeding, diarrhea, low albumin, capsule findings, enterography, stricture risk, and safer medication options.
The pathway moved from anemia, diarrhea, pain, or obstruction to NSAID exposure review, small-bowel testing, withdrawal of the causative medicine, and treatment of complications.
Michael first noticed reduced stamina rather than abdominal pain.
Review NSAID enteritis →A falling ferritin and hemoglobin established chronic blood loss or impaired iron balance.
Review abdominal pain →Capsule endoscopy and, when needed, enterography or device-assisted enteroscopy were used according to lesion pattern and stricture risk.
Review capsule endoscopy →Ibuprofen and naproxen were discontinued after coordination with the clinician managing chronic pain.
Schedule follow-up →The pathway depends on NSAID exposure, bleeding, anemia, diarrhea, protein loss, suspected stricture, obstruction risk, and whether Crohn’s disease or another small-bowel disorder remains plausible.
The team documented ibuprofen, naproxen, diclofenac, aspirin, prescription NSAIDs, dose, duration, combination use, and the reason each drug was needed.
Hemoglobin, ferritin, iron studies, stool color, anticoagulants, and bleeding symptoms were assessed.
Capsule endoscopy and, when needed, enterography or device-assisted enteroscopy were used according to lesion pattern and stricture risk.
Ibuprofen and naproxen were discontinued after coordination with the clinician managing chronic pain.
Mucosal-protective agents such as misoprostol may be considered in selected patients, especially when antiplatelet therapy cannot be stopped, but they are not universal first-line treatment for every case.
Suspected small-bowel stricture changes capsule-endoscopy safety. Persistent vomiting, marked distension, heavy bleeding, or severe pain requires urgent evaluation.
NSAID dose and duration, lesion distribution, bleeding, anemia, protein loss, stricture risk, imaging, capsule findings, pathology, and competing diagnoses are interpreted together.
Nonsteroidal anti-inflammatory drugs can damage the small bowel and produce erythema, erosions, ulcers, bleeding, protein loss, and fibrotic strictures.
Small-bowel NSAID injury may bleed slowly enough that anemia is the main clue rather than visible blood.
Capsule endoscopy can visualize mucosal lesions throughout much of the small bowel after adequate assessment for retention risk.
Crohn’s disease, infection, celiac disease, tumors, vascular lesions, and other causes must be considered according to the pattern.
When clinically possible, withdrawal of the causative NSAID is the most direct way to remove ongoing injury.
The consultation connected medication exposure with the exact small-bowel consequence and the safest diagnostic and treatment sequence.
The team documented ibuprofen, naproxen, diclofenac, aspirin, prescription NSAIDs, dose, duration, combination use, and the reason each drug was needed.
Hemoglobin, ferritin, iron studies, stool color, anticoagulants, and bleeding symptoms were assessed.
EGD and colonoscopy findings were reconciled to confirm that no adequate bleeding source had already been identified.
Capsule endoscopy and, when needed, enterography or device-assisted enteroscopy were used according to lesion pattern and stricture risk.
A safer long-term analgesic plan was coordinated so stopping NSAIDs did not leave the underlying pain untreated.
Treatment removes ongoing NSAID injury when possible, corrects bleeding or nutritional consequences, and treats established strictures or complications separately.
Ibuprofen and naproxen were discontinued after coordination with the clinician managing chronic pain.
Iron deficiency was treated while hemoglobin and ferritin were followed.
Mucosal-protective agents such as misoprostol may be considered in selected patients, especially when antiplatelet therapy cannot be stopped, but they are not universal first-line treatment for every case.
Acid suppression may be indicated for upper-GI risk but does not replace removal of the small-bowel NSAID exposure.
Persistent iron deficiency, pain, diarrhea, or weight loss prompted renewed evaluation.
Severe pain, persistent vomiting, marked distension, overt bleeding, or peritoneal signs required urgent assessment.
NSAID enteropathy may require gastroenterology, pain management, cardiology, advanced endoscopy, nutrition, hematology, or surgery depending on the complication.
The team documented ibuprofen, naproxen, diclofenac, aspirin, prescription NSAIDs, dose, duration, combination use, and the reason each drug was needed.
Capsule endoscopy and, when needed, enterography or device-assisted enteroscopy were used according to lesion pattern and stricture risk.
A safer long-term analgesic plan was coordinated so stopping NSAIDs did not leave the underlying pain untreated.
Mucosal-protective agents such as misoprostol may be considered in selected patients, especially when antiplatelet therapy cannot be stopped, but they are not universal first-line treatment for every case.
Coverage may differ for GI consultation, CBC and iron studies, capsule endoscopy, patency capsule, CT/MR enterography, device-assisted enteroscopy, endoscopic dilation, and surgery.
Include over-the-counter and prescription drugs, combination medicines, dose, frequency, and duration.
Provide CBC, ferritin, iron studies, albumin, weight trend, and transfusion history.
Capsule, enterography, EGD, colonoscopy, enteroscopy, and prior operative reports can change the next step.
Arthritis, cardiovascular disease, chronic pain, and other indications affect whether the medicine can safely be stopped.
The decision matched lesion type, bleeding or obstruction severity, NSAID necessity, alternative diagnoses, and the consequences of continued exposure.
Nonsteroidal anti-inflammatory drugs can damage the small bowel and produce erythema, erosions, ulcers, bleeding, protein loss, and fibrotic strictures.
Small-bowel NSAID injury may bleed slowly enough that anemia is the main clue rather than visible blood.
Capsule endoscopy and, when needed, enterography or device-assisted enteroscopy were used according to lesion pattern and stricture risk.
Ibuprofen and naproxen were discontinued after coordination with the clinician managing chronic pain.
NSAID small-bowel injury can look very different depending on whether the dominant problem is bleeding, inflammation, protein loss, or fibrosis.
Capsule endoscopy may show reddened folds, erosions, denuded areas, or ulcers causing pain or occult bleeding.
Best for: Patients with unexplained anemia or small-bowel symptoms after routine endoscopy
Limitations: Findings can overlap with Crohn’s disease and other enteropathies
Takeaway: Interpret lesions with medication exposure and the full differential
Chronic small-bowel blood loss can present mainly as falling ferritin or hemoglobin.
Best for: Patients with unexplained iron deficiency after upper and lower GI evaluation
Limitations: Other small-bowel bleeding sources must be excluded
Takeaway: The absence of visible blood does not exclude NSAID injury
Diffuse inflammation can contribute to enteric protein loss and hypoalbuminemia.
Best for: Patients with edema, low albumin, diarrhea, and compatible NSAID exposure
Limitations: Liver, kidney, heart, nutrition, and other enteropathies must be excluded
Takeaway: Treat the cause, not only the edema
Fibrotic ring-like narrowing can cause recurrent partial or complete small-bowel obstruction.
Best for: Long-term NSAID users with obstructive symptoms and short multifocal stenoses
Limitations: Capsule retention risk and need for intervention are higher
Takeaway: Assess patency before capsule and treat fixed narrowing separately
Heavy bleeding, obstruction, perforation, severe anemia, or dehydration can turn a chronic medication injury into an emergency.
How the chronic occult small-bowel bleeding and iron-deficiency anemia from NSAID enteropathy discovered by capsule endoscopy after nondiagnostic EGD and colonoscopy journey changed medication use, small-bowel symptoms, and follow-up
Ibuprofen and naproxen were discontinued after coordination with the clinician managing chronic pain.
Iron deficiency was treated while hemoglobin and ferritin were followed.
Persistent iron deficiency, pain, diarrhea, or weight loss prompted renewed evaluation.
Michael returned to daily responsibilities with a clearer understanding of which pain or cardiovascular medicines carried small-bowel risk and why medication changes needed coordination.
The patient also knew that new bleeding, severe pain, vomiting, or distension required prompt reassessment.
The stomach and colon scopes were reassuring, but the bleeding source was in the small bowel. My daily NSAID use finally made sense of the erosions and ulcers on capsule endoscopy.
This global patient journey is an educational composite illustrating chronic occult small-bowel bleeding and iron-deficiency anemia from NSAID enteropathy discovered by capsule endoscopy after nondiagnostic EGD and colonoscopy. It does not represent a specific patient. NSAID enteritis can cause small-bowel erosions, ulcers, occult or overt bleeding, protein loss, diaphragm-like strictures, obstruction, and rarely perforation. Diagnosis requires medication review and exclusion of other small-bowel disorders. Stopping an NSAID or aspirin may be unsafe when it is medically essential, so medication changes should be coordinated with the prescribing clinician. Heavy bleeding, severe pain, persistent vomiting, marked distension, fainting, or fever with worsening illness requires prompt medical assessment.
Answers about small-bowel NSAID injury, anemia, capsule endoscopy, diaphragm disease, Crohn’s mimics, aspirin, misoprostol, PPIs, and urgent warning signs
NSAID enteritis is injury to the small intestine caused by nonsteroidal anti-inflammatory drugs such as ibuprofen, naproxen, diclofenac, or aspirin. It can produce erosions, ulcers, bleeding, protein loss, strictures, and rarely perforation.
Yes. PPIs reduce upper-GI acid injury but do not reliably prevent NSAID-related small-bowel mucosal damage.
Many patients have few symptoms. Others develop abdominal pain, diarrhea, iron-deficiency anemia, occult or overt bleeding, low albumin, weight loss, or obstructive symptoms.
Diagnosis uses medication history plus exclusion of competing causes and may involve capsule endoscopy, CT or MR enterography, device-assisted enteroscopy, laboratory testing, or surgery depending on the presentation.
It is a rare complication in which thin fibrotic ring-like strictures form in the small bowel and can cause partial or complete obstruction.
Capsule endoscopy is useful for mucosal lesions and obscure small-bowel bleeding, but suspected strictures should be assessed first because the capsule can become retained.
When medically possible, stopping the causative NSAID is foundational. Iron, nutrition, bleeding treatment, alternative pain therapy, and treatment of strictures are added according to the problem.
Misoprostol has evidence for healing aspirin-associated small-bowel ulcers in selected patients who must continue aspirin, but it is not a universal treatment and can cause diarrhea or cramping.
Yes. Both can cause ileitis, erosions, ulcers, bleeding, and strictures, so medication exposure, pathology, imaging, chronicity, and response after NSAID withdrawal matter.
Seek urgent care for heavy bleeding, black tarry stool with weakness, severe pain, persistent vomiting, marked distension, inability to pass gas or stool, fainting, or fever with worsening illness.
Explore related condition, symptom, and procedure guides connected with NSAID enteropathy.
Review causes, bleeding, ulcers, protein loss, diaphragm disease, diagnosis, and treatment.
Condition Guide →Review GI causes of chronic blood loss and when small-bowel evaluation is considered.
Anemia Guide →Understand vomiting, distension, cramping, and urgent evaluation of obstructive symptoms.
Obstruction Guide →Learn how capsule endoscopy evaluates small-bowel mucosal disease and bleeding.
Capsule Guide →Arrange stable review of NSAID exposure, anemia, capsule findings, enterography, and small-bowel complications.
Book Appointment →Document every prescription and over-the-counter NSAID or aspirin, dose, duration, indication, and combination use.
Determine whether the dominant issue is occult bleeding, ulceration, diarrhea, protein loss, stricture, or obstruction.
Use capsule endoscopy for mucosal disease when appropriate and enterography or patency assessment when narrowing is suspected.
Ibuprofen and naproxen were discontinued after coordination with the clinician managing chronic pain.
Mucosal-protective agents such as misoprostol may be considered in selected patients, especially when antiplatelet therapy cannot be stopped, but they are not universal first-line treatment for every case.
Severe pain, persistent vomiting, marked distension, overt bleeding, or peritoneal signs required urgent assessment.
GastroDoxs can review NSAID exposure, iron-deficiency anemia, occult bleeding, low albumin, capsule findings, enterography, stricture risk, and safer medication strategies.